Defense Verdict Returned In Connecticut Pradaxa Wrongful Death Trial

(March 27, 2018, 1:58 PM EDT) -- HARTFORD, Conn. — A Connecticut state court jury on March 23 said Boehringer Ingelheim Pharmaceuticals Inc. failed to provide an adequate warning that its Pradaxa anticoagulant could cause uncontrolled internal bleeding...
To view the full article, register now.